Skip to main content
创远信科 logo

创远信科 — Investor Relations & Filings

Ticker · 920961 Beijing Stock Exchange Manufacturing
Filings indexed 657 across all filing types
Latest filing 2023-10-26 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920961

About 创远信科

https://www.transcom.net.cn/

Transcom Instruments specializes in the research, development, and manufacturing of high-end wireless communication testing and measurement equipment. The company provides a comprehensive suite of solutions including vector network analyzers, signal generators, spectrum analyzers, and wireless network optimization tools. Its product portfolio serves critical sectors such as telecommunications, aerospace, defense, and automotive electronics. Transcom is recognized for its expertise in RF and microwave technology, offering advanced testing capabilities for 5G and emerging 6G standards. By focusing on independent innovation, the company delivers high-precision instruments and integrated testing systems designed to ensure the reliability and performance of wireless infrastructure and mobile devices.

Recent filings

Filing Released Lang Actions
上海荣正企业咨询服务(集团)股份有限公司关于创远信科(上海)技术股份有限公司2023年股票期权激励计划(草案)之独立财务顾问报告
Capital/Financing Update Classification · 95% confidence The document is an Independent Financial Advisor Report regarding a 2023 stock option incentive plan for a company. It contains detailed descriptions of the stock option plan, including scope, allocation, terms, conditions, pricing, and compliance with relevant laws and regulations. The document is lengthy (15,000 characters) and contains substantive content related to the stock option incentive plan, including financial and legal analysis. It is not a brief announcement or a certification letter. The content aligns with a detailed advisory report on a capital/financing activity, specifically a stock option incentive plan, which is a form of capital/financing update. Therefore, the document should be classified as a Capital/Financing Update (CAP).
2023-10-26 Chinese
关于取得美国专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a US patent certificate. It includes details about the patent type, patent number, and the company's cumulative patent applications and grants. There is no financial data, no mention of financial results, no regulatory certifications, or meeting-related materials. The document is an official announcement about intellectual property achievements, which does not fit into financial reports, management changes, or other specific categories. It is a regulatory announcement informing investors about a corporate development. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2023-10-08 Chinese
关于公司与长春汽车检测中心有限责任公司成立智能网联汽车测试联合实验室的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the establishment of a joint laboratory between the company and another entity. It details the cooperation, the parties involved, and the expected impact on the company. There is no financial data, no mention of a report being published or attached, and no regulatory certification. The content is about a corporate cooperation event and its implications, which fits best under general regulatory announcements. It does not fit into any specific financial report or meeting-related category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-09-12 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding the lifting of trading restrictions on certain shares of the company 创远信科(上海)技术股份有限公司. It details the number of shares becoming tradable, the shareholders involved, reasons for lifting restrictions, and the updated share capital structure. There is no financial data, earnings information, or management discussion. The document is a regulatory announcement about share status changes, specifically about stock restriction removal, which fits the category of Share Issue/Capital Change (SHA). The document length is short and focused on share capital changes, not a full report or earnings release.
2023-09-07 Chinese
关于接待机构投资者调研情况的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about a recent investor research or inquiry session held on August 29, 2023. It includes questions from institutional investors and the company's responses regarding business operations, financial performance, market competition, product development, and employee matters. The document does not contain detailed financial statements or comprehensive financial analysis typical of an interim or annual report. It is not a transcript of a conference call but rather a summary of investor Q&A. The document length is relatively short (2215 characters), and it is an announcement of the investor research session and company replies. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like earnings release or management report.
2023-08-28 Chinese
关于接待机构投资者调研情况的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the reception of institutional investor research inquiries and the company's responses. It includes details about the date of the research (August 29, 2023), the participating institutions, and answers to questions about the company's business performance, strategy, market competition, product development, and employee incentives. The document does not contain financial statements or detailed financial data but rather a summary of investor Q&A and company commentary. It is not a full financial report, earnings release, or regulatory filing of financial results. It is also not a report publication announcement since it contains substantive content rather than just a notice of report availability. This type of document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories such as earnings release, annual report, or management report.
2023-08-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.